What will it take? Perspectives from five low- and middle-income countries on opportunities and challenges of introducing new maternal vaccines.

Autor: Baral R; PATH, Seattle, United States of America., Fleming JA; PATH, Seattle, United States of America. Electronic address: jfleming@path.org., Barros I; PATH, Maputo, Mozambique., Cofie P; PATH, Accra, Ghana., Dapaah P; PATH, Accra, Ghana., Khan S; PATH, Seattle, United States of America., Knudson SJ; PATH, Seattle, United States of America., Kumar S; PATH, New Delhi, India., Mehedi K; PATH, Dhaka, Bangladesh., Munywoki PK; Kenya Medical Research Institute - Wellcome Trust Research Programme (KEMRI - WTRP), Kilifi, Kenya., Newhouse L; PATH, Seattle, United States of America., Nyawanda BO; Kenya Medical Research Institute - Center for Global Health Research (KEMRI - CGHR), Kisumu, Kenya., Nyiro JU; Kenya Medical Research Institute - Wellcome Trust Research Programme (KEMRI - WTRP), Kilifi, Kenya., Odiyo J; Independent Consultant, Nairobi, Kenya., Otiang E; PATH, Nairobi, Kenya., Owusu R; Independent Consultant, Accra, Ghana., Pecenka C; PATH, Seattle, United States of America., Picolo M; PATH, Maputo, Mozambique., Pinto J; PATH, Maputo, Mozambique., Quelhas D; Independent Consultant, Maputo, Mozambique., Routray S; PATH, New Delhi, India., Sultana S; Independent Consultant, Dhaka, Bangladesh., Uranw S; B.P. Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
Jazyk: angličtina
Zdroj: Vaccine [Vaccine] 2024 Dec 24; Vol. 45, pp. 126654. Date of Electronic Publication: 2024 Dec 24.
DOI: 10.1016/j.vaccine.2024.126654
Abstrakt: Background: New vaccines for pregnant women have recently been introduced in some high-income countries to protect infants in early life. Implementing maternal immunisation (MI) successfully in low- and middle-income countries will require planning and adaptations to immunisation and maternal health programs. To inform cost of MI delivery studies, we gathered perspectives from key stakeholders in five countries (Bangladesh, Ghana, Kenya, Mozambique, and Nepal) regarding health system requirements, opportunities, and challenges to introducing new maternal vaccines into routine health programs.
Methods: We convened national stakeholders for country workshops to deliberate potential delivery strategies, opportunities, and constraints for implementing new MI interventions. Divided into thematic areas, participants discussed health system adaptations needed to establish or strengthen an MI platform.
Findings: Stakeholders felt that existing programs that administer vaccines to pregnant women, primarily tetanus-containing vaccines, provide a proven path for the delivery of additional maternal vaccines. Maternal health and immunisation program integration was perceived strongest at the health care provision level and weakest at the national level. Concerted coordination at the national level was identified as critical to the success of introducing new interventions. Stakeholders perceived that most health workforce providing immunisation and antenatal care services undergo similar training and have transferrable skills, however developing operational guidelines with clear roles and responsibilities was deemed critical for ownership and accountability. Human resource constraints were cited as a challenge for some countries. The importance of raising awareness of disease burden and new MI interventions was also highlighted across countries. Sustainable financing was a recurring challenge cited, especially with transitions from Gavi support.
Conclusions: The workshops enabled country stakeholders to deliberate needs to support the introduction of new maternal vaccines. While circumstances and needs differed, stakeholders across countries were optimistic about the capability of their health systems to integrate new maternal vaccines.
Competing Interests: Declaration of competing interest All authors have no competing interests to declare.
(Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: